Reading Time: 3 minutesResearchers from University College London led by Dr Pietro Fratta and Dr John Thornton found that muscle imaging can help distinguish Amyotrophic Lateral Sclerosis (ALS)
Category: Markers of Disease Progression
Causes and disease mechanisms Clinical Trials Markers of Disease Progression MND Research Models of MND Research we fund Treatments
How animals are helping to improve our understanding of MND
Reading Time: 6 minutes‘From antibiotics and insulin to blood transfusions and treatments for cancer or HIV, virtually every medical achievement in the past century has depended directly or
Reading Time: 3 minutesThis blog is part of the ‘Highlights from Glasgow’ collection of articles, where you can read about the content of some of the talks and
Reading Time: 4 minutesThis blog is part of the ‘Highlights from Glasgow’ collection of articles, where you can read about the content of some of the talks and
Reading Time: 7 minutesIn the last decade, the MND Association has invested millions in research within the UK and across the world. We are a leader in the
Reading Time: 3 minutesIt has been almost a year since we announced that AMBRoSIA (A Multicentre Biomarker Resource Strategy In ALS) had begun to recruit participants (read the
Causes and disease mechanisms Clinical Trials Markers of Disease Progression MND Research Research we fund
Lighthouse Project shines a beacon on HERVs and their role in ALS
Reading Time: 3 minutesThere is recent evidence to suggest that Human Endogenous Retroviruses (HERVs) may be involved in amyotrophic lateral sclerosis (ALS). HERV-K has been directly linked to
Reading Time: 5 minutesEach year, the MND Association dedicates the month of June to raising MND awareness. This year, we focus on the eyes – in most people
Reading Time: 3 minutesResearchers from the Flinders University, Australia and University of Miami have discovered a new protein that can act as a biomarker to track disease progression